-
EP3601239
European procedure
Extract from the Register of European Patents
EP About this file: EP3601239
| EP3601239 - NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.06.2025 Database last updated on 31.03.2026 | |
| Former | The patent has been granted Status updated on 27.06.2024 | ||
| Former | Grant of patent is intended Status updated on 19.02.2024 | ||
| Former | Examination is in progress Status updated on 31.03.2023 | ||
| Former | Grant of patent is intended Status updated on 29.11.2022 | ||
| Former | Examination is in progress Status updated on 28.10.2022 | ||
| Former | Grant of patent is intended Status updated on 21.06.2022 | ||
| Former | Examination is in progress Status updated on 27.05.2022 | ||
| Former | Grant of patent is intended Status updated on 25.01.2022 | ||
| Former | Examination is in progress Status updated on 03.04.2021 | ||
| Former | Request for examination was made Status updated on 03.01.2020 | ||
| Former | The international publication has been made Status updated on 29.09.2018 | Most recent event Tooltip | 06.06.2025 | No opposition filed within time limit | published on 09.07.2025 [2025/28] | Applicant(s) | For all designated states Jacobio Pharmaceuticals Co., Ltd. Unit 2, Building 5, BYBP No.88 Kechuang Street 6th Business Development Area Daxing Beijing 101111 / CN | [2024/31] |
| Former [2020/06] | For all designated states Jacobio Pharmaceuticals Co., Ltd. Unit 2, Building 5, BYBP No.88 Kechuang Street 6th Business Development Area Daxing Beijing 101111 / CN | Inventor(s) | 01 /
MA, Cunbo Unit 2 Building 5 BYBP No.88 Kechuang Street 6th Business Development Area, Daxing Beijing 101111 / CN | 02 /
GAO, Panliang Unit 2 Building 5 BYBP No.88 Kechuang Street 6th Business Development Area, Daxing Beijing 101111 / CN | 03 /
HU, Shaojing Unit 2 Building 5 BYBP No.88 Kechuang Street 6th Business Development Area, Daxing Beijing 101111 / CN | 04 /
XU, Zilong Unit 2 Building 5 BYBP No.88 Kechuang Street 6th Business Development Area, Daxing Beijing 101111 / CN | 05 /
HAN, Huifeng Unit 2 Building 5 BYBP No.88 Kechuang Street 6th Business Development Area, Daxing Beijing 101111 / CN | 06 /
WU, Xinping Unit 2 Building 5 BYBP No.88 Kechuang Street 6th Business Development Area, Daxing Beijing 101111 / CN | 07 /
KANG, Di Unit 2 Building 5 BYBP No.88 Kechuang Street 6th Business Development Area, Daxing Beijing 101111 / CN | [2020/06] | Representative(s) | Mathys & Squire 32 London Bridge Street The Shard London SE1 9SG / GB | [N/P] |
| Former [2024/31] | Arch, Peter Jonathan Sanders, et al Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB | ||
| Former [2020/06] | Sun, Yiming HUASUN Patent- und Rechtsanwälte Friedrichstraße 33 80801 München / DE | Application number, filing date | 18770877.1 | 23.03.2018 | [2020/06] | WO2018IB51973 | Priority number, date | WO2017IB51690 | 23.03.2017 Original published format: PCT/IB2017/051690 | [2020/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018172984 | Date: | 27.09.2018 | Language: | EN | [2018/39] | Type: | A1 Application with search report | No.: | EP3601239 | Date: | 05.02.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.09.2018 takes the place of the publication of the European patent application. | [2020/06] | Type: | B1 Patent specification | No.: | EP3601239 | Date: | 31.07.2024 | Language: | EN | [2024/31] | Search report(s) | International search report - published on: | CN | 27.09.2018 | (Supplementary) European search report - dispatched on: | EP | 17.04.2020 | Classification | IPC: | C07D401/14, C07D491/107, C07D495/10, C07D471/20, A61K31/497, A61P35/00, C07D405/14, C07D491/113, C07D491/20, C07D513/10, C07F9/6558, C07D471/10 | [2020/20] | CPC: |
A61P35/00 (EP,EA,KR);
C07D401/14 (EP,EA,KR,US);
C07D413/14 (US);
A61K31/497 (KR);
A61K31/5377 (KR);
A61P27/02 (KR);
A61P35/04 (KR);
A61P37/00 (KR);
A61P43/00 (KR);
A61P9/00 (KR);
C07D401/04 (KR,US);
C07D405/14 (EP,EA);
C07D471/10 (EP,EA,KR,US);
C07D471/20 (EP,EA,KR,US);
C07D491/107 (EP,EA,KR,US);
C07D491/113 (EP,EA);
C07D491/20 (EP,EA);
C07D495/10 (EP,EA,KR,US);
|
| Former IPC [2020/06] | C07D241/18, C07D241/20, C07D401/14, C07D401/04, C07D491/107, C07D498/10, C07D471/10, A61K31/497, A61P35/00, A61P35/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/06] | Extension states | BA | 23.10.2019 | ME | 23.10.2019 | Validation states | MA | 23.10.2019 | MD | 23.10.2019 | TN | 23.10.2019 | Title | German: | NEUARTIGE, ALS SHP2-INHIBITOREN NÜTZLICHE HETEROCYCLISCHE DERIVATE | [2020/06] | English: | NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS | [2020/06] | French: | NOUVEAUX DÉRIVÉS HÉTÉROCYCLIQUES UTILES EN TANT QU'INHIBITEURS DE SHP2 | [2020/06] | Entry into regional phase | 23.10.2019 | National basic fee paid | 23.10.2019 | Search fee paid | 23.10.2019 | Designation fee(s) paid | 23.10.2019 | Examination fee paid | Examination procedure | 23.10.2019 | Examination requested [2020/06] | 17.11.2020 | Amendment by applicant (claims and/or description) | 08.04.2021 | Despatch of a communication from the examining division (Time limit: M04) | 18.08.2021 | Reply to a communication from the examining division | 26.01.2022 | Communication of intention to grant the patent | 26.05.2022 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 22.06.2022 | Communication of intention to grant the patent | 27.10.2022 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 30.11.2022 | Communication of intention to grant the patent | 29.03.2023 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 24.04.2023 | Despatch of a communication from the examining division (Time limit: M06) | 03.11.2023 | Reply to a communication from the examining division | 20.02.2024 | Communication of intention to grant the patent | 19.06.2024 | Fee for grant paid | 19.06.2024 | Fee for publishing/printing paid | 19.06.2024 | Receipt of the translation of the claim(s) | Divisional application(s) | EP24191584.2 Application deemed to be withdrawn : 30.01.2025 | Opposition(s) | 01.05.2025 | No opposition filed within time limit [2025/28] | Fees paid | Renewal fee | 24.03.2020 | Renewal fee patent year 03 | 09.03.2021 | Renewal fee patent year 04 | 16.03.2022 | Renewal fee patent year 05 | 13.03.2023 | Renewal fee patent year 06 | 01.03.2024 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XP] WO2016203406 (NOVARTIS AG et al.) [XP] 1-3,6,8,11,12,15-18,20,21,26,38-43 | [XA] WO2015107495 (NOVARTIS AG et al.) [X] 1-4,9,15-17,22,23,26,38-43 * formula Ia with p = q =1;; claims 1-10,12-14 *[A] 6-8,10-14,18-21,24,25,27-37 | [XA] WO2017211303 (JACOBIO PHARMACEUTICALS CO LTD et al.) [X] 1-4,9,15-17,22,23,26,38-43 * paragraphs [0029] , [0033]; claims 2-9, 22-23 *[A] 6-8,10-14,18-21,24,25,27-37 | [XP] WO2007057775 (PFIZER LTD et al.) [XP] 1-3,6,8,11,12,15-18,20,21,26,38-43 * claims 1,29,35 * | International search | [PX] WO2018013597 (REVOLUTION MEDICINES INC et al.) [PX] 1-130 * claims, examples * | [X] WO2016203406 (NOVARTIS AG et al.) [X] 1-130 * claims 1, 4-14, examples * | [X] WO2015107495 (NOVARTIS AG et al.) [X] 1-130 * examples, claims * | [A] WO2015107494 (NOVARTIS AG et al.) [A] 1-130 * claims, examples * | Examination | WO2017211303 | by applicant | WO2017211303 | "Design of Prodrugs", 1985, ELSEVIER | Y. UTO ET AL., BIOORG. MED. CHEM. LETT., vol. 20, 2010, pages 746 - 754 | J. ORG. CHEM., vol. 64, 1999, pages 5504 - 5510 | "REMINGTON: THE SCIENCE AND PRACTICE OF PHARMACY", 1995, MACK PUBLISHING CO. |